GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (NAS:FBLG) » Definitions » NonCurrent Deferred Liabilities

FibroBiologics (FibroBiologics) NonCurrent Deferred Liabilities : $0.00 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

FibroBiologics's non-current deferred liabilities for the quarter that ended in Mar. 2024 was $0.00 Mil.

FibroBiologics NonCurrent Deferred Liabilities Historical Data

The historical data trend for FibroBiologics's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics NonCurrent Deferred Liabilities Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23
NonCurrent Deferred Liabilities
- - -

FibroBiologics Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only - - - - -

FibroBiologics NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of FibroBiologics's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


FibroBiologics (FibroBiologics) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
Address
455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
FibroBiologics Inc is an early-stage, cell therapy company. Its primary focus is the initiation and progression of preclinical studies and clinical-stage FDA trials related to fibroblast treatments for Degenerative Disc Disease, Multiple Sclerosis, Cancer, Wound Healing, and other diseases.

FibroBiologics (FibroBiologics) Headlines